Your browser doesn't support javascript.
loading
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.
McLornan, D; Eikema, D J; Czerw, T; Kröger, N; Koster, L; Reinhardt, Hans Christian; Angelucci, E; Robin, M; Bornhäuser, M; Passweg, J; Clark, A; Vydra, J; Blau, I E; Niittyvuopio, R; Platzbecker, U; Cornelissen, J J; Chevallier, P; Srour, M; Stamatovic, D; Martinez-Lopez, J; de Wreede, L; Hayden, P; Hernández-Boluda, J C; Yakoub-Agha, I.
Affiliation
  • McLornan D; Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust and University College Hospital, London, UK. donal.mclornan@nhs.net.
  • Eikema DJ; Department of Medical Statistics, Leiden University Medical Centre, Leiden, The Netherlands.
  • Czerw T; Maria Sklodowska-Curie Memorial Cencer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
  • Kröger N; Division of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
  • Koster L; EBMT Data Office, Leiden, The Netherlands.
  • Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center University Hospital Essen, Essen, Germany.
  • Angelucci E; Hematologia and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Robin M; Hôpital Saint-Louis, Service d'Hématologie-Greffe, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Bornhäuser M; Universitaetsklinikum Dresden, Dresden, Germany.
  • Passweg J; Klinik für Hämatologie,Bereich Innere Medizin, Universitätsspital Basel, Basel, Switzerland.
  • Clark A; Department of Haematology and Stem Cell Transplant, Beatson Centre, Glasgow, Scotland.
  • Vydra J; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Blau IE; Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki, Finland.
  • Platzbecker U; University Hospital Leipzig, Leipzig, Germany.
  • Cornelissen JJ; Department of Haematology, Erasmus MC/Daniel den Hoed Cancer Center, Rottrdam, The Netherlands.
  • Chevallier P; CHU Nantes, Nantes, France.
  • Srour M; Centre Hospitalier Régional Universitaire de Lille, Hospital Claude Huriez, Huriez, France.
  • Stamatovic D; Department of Haematology, Military Medical Academy, Belgrade, Serbia.
  • Martinez-Lopez J; Hospital Universitario 12 de Octubre, Avd de Cordoba s/n, Madrid, Spain.
  • de Wreede L; Department of Medical Statistics, Leiden University Medical Centre, Leiden, The Netherlands.
  • Hayden P; Department of Haematology, St.James Hospital, Dublin, Ireland.
  • Hernández-Boluda JC; Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Yakoub-Agha I; Service des Maladies du Sang, CHRU de Lille, LIRIC, INSERM U995, Universite de Lille, Lille, France. ibrahim.yakoubagha@chru-lille.fr.
Bone Marrow Transplant ; 56(9): 2160-2172, 2021 09.
Article in En | MEDLINE | ID: mdl-33911203
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis / Graft vs Host Disease Type of study: Observational_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Primary Myelofibrosis / Graft vs Host Disease Type of study: Observational_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United kingdom